Amplitude Surgical (XPAR:AMPLI) Debt-to-Equity : 1.19 (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Amplitude Surgical Debt-to-Equity?

Amplitude Surgical's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €14.0 Mil. Amplitude Surgical's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €98.8 Mil. Amplitude Surgical's Total Stockholders Equity for the quarter that ended in Dec. 2023 was €94.7 Mil. Amplitude Surgical's debt to equity for the quarter that ended in Dec. 2023 was 1.19.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Amplitude Surgical's Debt-to-Equity or its related term are showing as below:

XPAR:AMPLI' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.62 Med: 1.39 Max: 10.85
Current: 1.19

During the past 13 years, the highest Debt-to-Equity Ratio of Amplitude Surgical was 10.85. The lowest was 0.62. And the median was 1.39.

XPAR:AMPLI's Debt-to-Equity is ranked worse than
90.55% of 709 companies
in the Medical Devices & Instruments industry
Industry Median: 0.21 vs XPAR:AMPLI: 1.19

Amplitude Surgical Debt-to-Equity Historical Data

The historical data trend for Amplitude Surgical's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amplitude Surgical Debt-to-Equity Chart

Amplitude Surgical Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Debt-to-Equity

Get a 7-Day Free Trial

1.43

1.99

2.49

2.57

1.11

Amplitude Surgical Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial															2.58	2.57	2.70	1.11	1.19

Competitive Comparison of Amplitude Surgical's Debt-to-Equity

For the Medical Instruments & Supplies subindustry, Amplitude Surgical's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Amplitude Surgical's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Amplitude Surgical's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Amplitude Surgical's Debt-to-Equity falls into.

Amplitude Surgical Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Amplitude Surgical's Debt to Equity Ratio for the fiscal year that ended in Jun. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(11.255	+	95.223)	/	95.813
	=	1.11

Amplitude Surgical's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(14.041	+	98.819)	/	94.669
	=	1.19

Amplitude Surgical (XPAR:AMPLI) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Amplitude Surgical Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Amplitude Surgical's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Amplitude Surgical (XPAR:AMPLI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Amplitude Surgical (XPAR:AMPLI) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

1AU:Germany

Address

11 cours Jacques Offenbach, Valence, FRA, 26000

Website

https://www.amplitude-surgical.com

Amplitude Surgical is engaged in developing and marketing products for orthopedic surgery. It offers a range of orthopedic products for primary and revision surgery aimed at treating pathologies of the hip, knee, and lower extremities for foot and ankle surgery. The company also provides AMPLIVISION, a computer-assisted surgical system; the i.M.A.G.E., a single-use made-to-measure instrument system; and the E.T.O.I.L.E, a technology platform for anterior approaches resulting in less-invasive surgery.

Amplitude Surgical (XPAR:AMPLI) Headlines

No Headlines